ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell... ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.13 | 5.60344827586 | 2.32 | 2.58 | 2.3 | 1427046 | 2.39423611 | CS |
4 | 0.26 | 11.8721461187 | 2.19 | 2.58 | 2.07 | 690139 | 2.37602003 | CS |
12 | -0.058 | -2.31259968102 | 2.508 | 2.58 | 1.58 | 574412 | 2.32544396 | CS |
26 | 1.08 | 78.8321167883 | 1.37 | 4.44 | 1.36 | 758622 | 2.59840939 | CS |
52 | -2.4 | -49.4845360825 | 4.85 | 5.29 | 1.12 | 785161 | 2.31656666 | CS |
156 | -6.95 | -73.9361702128 | 9.4 | 14.19 | 1.12 | 463300 | 4.06514234 | CS |
260 | -6.95 | -73.9361702128 | 9.4 | 14.19 | 1.12 | 463300 | 4.06514234 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.